














WuXi PharmaTech Files 2011 Annual Report on Form 20-F

WuXi PharmaTech Files 2011 Annual Report on Form 20-F -- SHANGHAI, April 20, 2012 /PRNewswire-Asia/ --
WuXi PharmaTech Files 2011 Annual Report on Form 20-F
SHANGHAI, April 20, 2012 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: [ WX ]) today announced that it filed its annual report on Form 20-F for the year ended December 31, 2011 with the Securities and Exchange Commission. The annual report can be accessed on WuXi PharmaTech's website at [ http://www.wuxiapptec.com ] under the Investor Relations/SEC Filings section. WuXi PharmaTech will provide a hard copy of its annual report on Form 20-F containing complete audited financial statements free of charge to its shareholders and ADS holders upon request. Requests should be directed to Ronald Aldridge, Director of Investor Relations, by email at [ ir@wuxiapptec.com ].
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec. For more information, please visit: [ http://www.wuxiapptec.com ] .
For more information, please contact:
WuXi PharmaTech (Cayman) Inc.
Ronald Aldridge (for investors)
Director of Investor Relations
Tel: +1-201-585-2048
Email: [ ir@wuxiapptec.com ]
Harry He (for the media)
Tel: +86-21-5046-4362
Email: [ pr@wuxiapptec.com ]
SOURCE WuXi PharmaTech (Cayman) Inc.
[ Back to top ] RELATED LINKS
[ http://www.wuxiapptec.com ]